Nurse Practitioner, Family · Ada, OK
NPI
1700361110
Since 2018
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1921 Stonecipher Dr
Ada, OK, 74820
Phone (580) 421-4532
Groups this clinician bills Medicare through
Medicare paid, 2024
$20K
418 services
Medicare patients, 2024
132
Average age 69
Drug cost, 2024
$2.0M
3,924 prescriptions
Company payments, 2025
$30.38
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Amanda D Moore was code 99214 (office e&m - established), 216 times for 96 patients. In total Amanda D Moore billed 418 services in 4 codes, and Medicare paid $20K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-11-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 216 | 96 | $53.84 | $12K |
| 95251 Test - Miscellaneous | Facility | 90 | 50 | $19.81 | $1,783 |
| 99214 Office E&M - Established | Office | 68 | 36 | $55.77 | $3,793 |
| 99215 Office E&M - Established | Facility | 23 | 22 | $71.74 | $1,650 |
By year: 2022 $7,307 for 102 services; 2023 $17K for 276 services; 2024 $20K for 418 services.
Medicare prescription drug claims, 2024
In 2024, the drug Amanda D Moore prescribed most often to Medicare patients was Ozempic (Semaglutide), with 658 prescriptions and refills. In total Amanda D Moore wrote 3,924 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 658 | 658 | 82 | $648K |
| Jardiance Empagliflozin | 588 | 592 | 79 | $372K |
| Metformin Hcl Generic | 263 | 263 | 34 | $13K |
| Trulicity Dulaglutide | 262 | 262 | 36 | $262K |
| Metformin Hcl Er Metformin Hcl | 226 | 228 | 30 | $6,843 |
| Tresiba Flextouch U-100 Insulin Degludec | 219 | 403 | 54 | $115K |
| Tresiba Flextouch U-200 Insulin Degludec | 161 | 192 | 29 | $131K |
| Novolog Flexpen Insulin Aspart | 159 | 249 | 54 | $29K |
| Rosuvastatin Calcium Generic | 132 | 132 | 19 | $18K |
| Pioglitazone Hcl Generic | 108 | 108 | 18 | $13K |
| Mounjaro Tirzepatide | 104 | 104 | 17 | $113K |
| Trueplus Pen Needle Pen Needle, Diabetic | 94 | 94 | 31 | $2,418 |
| Gvoke Hypopen 1-Pack Glucagon | 84 | 84 | 55 | $30K |
| Humulin R U-500 Kwikpen Insulin Regular, Human | 80 | 83 | 13 | $98K |
| Synthroid Levothyroxine Sodium | 75 | 75 | 12 | $3,671 |
Brand drugs: 2,714 claims; generic drugs: 1,040 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Amanda D Moore $30.38 ($30.38 in general payments such as food, travel and fees) from 2 companies. The largest payer was Corcept Therapeutics with $23.2.
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics CORT | 1 | $23.2 |
| CeQur Corporation | 1 | $7.18 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.